rxstat › Prices in Nova Scotia › Benralizumab
Benralizumab (Fasenra) price and coverage in Nova Scotia
Benralizumab 30 mg/ml solution lists at $4036.80 per billed unit in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Benralizumab is covered by Nova Scotia Pharmacare only under exception status: your prescriber has to request coverage, and it applies to patients who meet set criteria.
Price by strength in Nova Scotia
| Strength and form | Lowest price | Brand |
|---|---|---|
| 30 mg/ml Solution2 products · special approval | $4036.80/unit | – |
All 2 products listed in Nova Scotia
| Product | Price | Coverage |
|---|---|---|
| 30 mg/ml Solution | ||
| Fasenra PenAZE · DIN 02496135 | $4036.80/unit | Special approval |
| FasenraAZE · DIN 02473232 | $4115.54/unit | Special approval |
What you'll pay at the pharmacy
These are the prices Nova Scotia Pharmacare lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.
Shortage status
No active shortage is reported for Benralizumab in Canada. Full drug page.
Benralizumab price in other provinces
Common questions
How much does Benralizumab cost in Nova Scotia?
Benralizumab 30 mg/ml solution lists at $4036.80 per billed unit in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Is Benralizumab covered in Nova Scotia?
Benralizumab is covered by Nova Scotia Pharmacare only under exception status: your prescriber has to request coverage, and it applies to patients who meet set criteria.
Source: Nova Scotia Pharmacare Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.